ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Strensiq 40 mg/ml, Injektionslösung - 12
66086006 PPAlexion Pharma GmbH
Strensiq 40 mg/ml, Injektionslösung16.08.2016
  16.08.2016
Asfotase Alfa (A16AB13) 
WHO-DDD 
70000.12
07.14. 
A  
Yes 
IPCI
16609.24Yes
    
10 %17348.90
  
7680660860065Biotechnologika
  
Composition
asfotasum alfa 40.0 mg, natrii chloridum, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Asfotasum Alfa40 mg/ml
BAG: Active AgentDose
Asfotasum Alfa40 mg
 
Inactive agents
Disodium Phosphate Heptahydrate
Sodium Chloride
Sodium Dihydrogenophosphate Monohydrate
 
Source
Data was imported : 08.01.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home